Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Oct;134(10):2488-2491.
doi: 10.1038/jid.2014.245.

Metformin: a potential drug to treat hyperpigmentation disorders

Affiliations
Free article
Comment

Metformin: a potential drug to treat hyperpigmentation disorders

Elisabeth S Belisle et al. J Invest Dermatol. 2014 Oct.
Free article

Abstract

Hyperpigmentation disorders are generally difficult to treat because of the limited availability of effective therapeutics with minimal side effects. In this issue, Lehraiki et al. report that metformin, an antidiabetic drug, inhibited melanogenesis, in vitro and in vivo, and they suggest that metformin may be used to treat hyperpigmentation disorders. This commentary reviews the molecular mechanisms through which metformin inhibits melanogenesis and examines metformin as a potential drug to treat hyperpigmentation.

PubMed Disclaimer

Comment on

  • Inhibition of melanogenesis by the antidiabetic metformin.
    Lehraiki A, Abbe P, Cerezo M, Rouaud F, Regazzetti C, Chignon-Sicard B, Passeron T, Bertolotto C, Ballotti R, Rocchi S. Lehraiki A, et al. J Invest Dermatol. 2014 Oct;134(10):2589-2597. doi: 10.1038/jid.2014.202. Epub 2014 Apr 22. J Invest Dermatol. 2014. PMID: 24756109

References

    1. Exp Cell Res. 1998 Oct 10;244(1):117-24 - PubMed
    1. Atherosclerosis. 2014 Jan;232(1):156-64 - PubMed
    1. J Invest Dermatol. 2014 Oct;134(10):2589-2597 - PubMed
    1. J Invest Dermatol. 2004 Jan;122(1):159-66 - PubMed
    1. Clin Sci (Lond). 2012 Mar;122(6):253-70 - PubMed